Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1431-1440 of 1,472) with videos related to

Pageof 148
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
The discovery of BMS-457, a potent and selective CCR1 antagonistDaniel S Gardner, Joseph B Santella, John V Duncia, et al.
Haematologica|April 24, 2025
Production of platelets <i>in vitro</i> in functionalised 3-dimensional scaffolds mimicking the bone marrow nicheHolly R Foster, Maria Colzani, Guenaelle Bouet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.
Journal of Viral Hepatitis|March 12, 2022
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data setJake R Morgan, Elizabeth Marsh, Alexandra Savinkina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal AdenomaRobert E Schoen, Lisa A Boardman, Marcia Cruz-Correa, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical TrialDavid M Routman, Kathryn M Van Abel, Katharine A Price, et al.
Springerplus|September 3, 2016
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, et al.
Clinical Trials (London, England)|June 30, 2020
Mindfulness, Education, and Exercise for age-related cognitive decline: Study protocol, pilot study results, and description of the baseline sampleJulie Loebach Wetherell, Hayley S Ripperger, Michelle Voegtle, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySebastian Oltean, Yan Qiu, Joanne K Ferguson, et al.
Pageof 148

Showing results (1431-1440 of 1,472) with videos related to

Sort By:
Pageof 148
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
The discovery of BMS-457, a potent and selective CCR1 antagonistDaniel S Gardner, Joseph B Santella, John V Duncia, et al.
Haematologica|April 24, 2025
Production of platelets <i>in vitro</i> in functionalised 3-dimensional scaffolds mimicking the bone marrow nicheHolly R Foster, Maria Colzani, Guenaelle Bouet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.
Journal of Viral Hepatitis|March 12, 2022
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data setJake R Morgan, Elizabeth Marsh, Alexandra Savinkina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal AdenomaRobert E Schoen, Lisa A Boardman, Marcia Cruz-Correa, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical TrialDavid M Routman, Kathryn M Van Abel, Katharine A Price, et al.
Springerplus|September 3, 2016
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, et al.
Clinical Trials (London, England)|June 30, 2020
Mindfulness, Education, and Exercise for age-related cognitive decline: Study protocol, pilot study results, and description of the baseline sampleJulie Loebach Wetherell, Hayley S Ripperger, Michelle Voegtle, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySebastian Oltean, Yan Qiu, Joanne K Ferguson, et al.
Pageof 148